Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Heparin Market, By Type
7.1. Heparin Market, By Type, 2020-2028
7.1.1. Low Molecular Weight Heparin
7.1.1.1. Market Revenue and Forecast (2016-2028)
7.1.2. Ultra-low Molecular Weight Heparin
7.1.2.1. Market Revenue and Forecast (2016-2028)
7.1.3. Unfractionated Heparin
7.1.3.1. Market Revenue and Forecast (2016-2028)
Chapter 8. Global Heparin Market, By Application
8.1. Heparin Market, by Application, 2020-2028
8.1.1. Venous Thromboembolism
8.1.1.1. Market Revenue and Forecast (2016-2028)
8.1.2. Atrial Fibrillation
8.1.2.1. Market Revenue and Forecast (2016-2028)
8.1.3. Renal Impairment
8.1.3.1. Market Revenue and Forecast (2016-2028)
8.1.4. Coronary Artery Disease
8.1.4.1. Market Revenue and Forecast (2016-2028)
Chapter 9. Global Heparin Market, By End User
9.1. Heparin Market, by End User, 2020-2028
9.1.1. Outpatient
9.1.1.1. Market Revenue and Forecast (2016-2028)
9.1.2. Inpatient
9.1.2.1. Market Revenue and Forecast (2016-2028)
Chapter 10. Global Heparin Market, By Route of Administration
10.1. Heparin Market, By Route of Administration, 2020-2028
10.1.1. Intravenous
10.1.1.1. Market Revenue and Forecast (2016-2028)
10.1.2. Subcutaneous
10.1.2.1. Market Revenue and Forecast (2016-2028)
Chapter 11. Global Heparin Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, By Type (2016-2028)
11.1.2. Market Revenue and Forecast, by Application (2016-2028)
11.1.3. Market Revenue and Forecast, by End User (2016-2028)
11.1.4. Market Revenue and Forecast, By Route of Administration (2016-2028)
11.1.5. U.S.
11.1.5.1. Market Revenue and Forecast, By Type (2016-2028)
11.1.5.2. Market Revenue and Forecast, by Application (2016-2028)
11.1.5.3. Market Revenue and Forecast, by End User (2016-2028)
11.1.5.4. Market Revenue and Forecast, By Route of Administration (2016-2028)
11.1.6. Rest of North America
11.1.6.1. Market Revenue and Forecast, By Type (2016-2028)
11.1.6.2. Market Revenue and Forecast, by Application (2016-2028)
11.1.6.3. Market Revenue and Forecast, by End User (2016-2028)
11.1.6.4. Market Revenue and Forecast, By Route of Administration (2016-2028)
11.2. Europe
11.2.1. Market Revenue and Forecast, By Type (2016-2028)
11.2.2. Market Revenue and Forecast, by Application (2016-2028)
11.2.3. Market Revenue and Forecast, by End User (2016-2028)
11.2.4. Market Revenue and Forecast, By Route of Administration (2016-2028)
11.2.5. UK
11.2.5.1. Market Revenue and Forecast, By Type (2016-2028)
11.2.5.2. Market Revenue and Forecast, by Application (2016-2028)
11.2.5.3. Market Revenue and Forecast, by End User (2016-2028)
11.2.5.4. Market Revenue and Forecast, By Route of Administration (2016-2028)
11.2.6. Germany
11.2.6.1. Market Revenue and Forecast, By Type (2016-2028)
11.2.6.2. Market Revenue and Forecast, by Application (2016-2028)
11.2.6.3. Market Revenue and Forecast, by End User (2016-2028)
11.2.6.4. Market Revenue and Forecast, By Route of Administration (2016-2028)
11.2.7. France
11.2.7.1. Market Revenue and Forecast, By Type (2016-2028)
11.2.7.2. Market Revenue and Forecast, by Application (2016-2028)
11.2.7.3. Market Revenue and Forecast, by End User (2016-2028)
11.2.7.4. Market Revenue and Forecast, By Route of Administration (2016-2028)
11.2.8. Rest of Europe
11.2.8.1. Market Revenue and Forecast, By Type (2016-2028)
11.2.8.2. Market Revenue and Forecast, by Application (2016-2028)
11.2.8.3. Market Revenue and Forecast, by End User (2016-2028)
11.2.8.4. Market Revenue and Forecast, By Route of Administration (2016-2028)
11.3. APAC
11.3.1. Market Revenue and Forecast, By Type (2016-2028)
11.3.2. Market Revenue and Forecast, by Application (2016-2028)
11.3.3. Market Revenue and Forecast, by End User (2016-2028)
11.3.4. Market Revenue and Forecast, By Route of Administration (2016-2028)
11.3.5. India
11.3.5.1. Market Revenue and Forecast, By Type (2016-2028)
11.3.5.2. Market Revenue and Forecast, by Application (2016-2028)
11.3.5.3. Market Revenue and Forecast, by End User (2016-2028)
11.3.5.4. Market Revenue and Forecast, By Route of Administration (2016-2028)
11.3.6. China
11.3.6.1. Market Revenue and Forecast, By Type (2016-2028)
11.3.6.2. Market Revenue and Forecast, by Application (2016-2028)
11.3.6.3. Market Revenue and Forecast, by End User (2016-2028)
11.3.6.4. Market Revenue and Forecast, By Route of Administration (2016-2028)
11.3.7. Japan
11.3.7.1. Market Revenue and Forecast, By Type (2016-2028)
11.3.7.2. Market Revenue and Forecast, by Application (2016-2028)
11.3.7.3. Market Revenue and Forecast, by End User (2016-2028)
11.3.7.4. Market Revenue and Forecast, By Route of Administration (2016-2028)
11.3.8. Rest of APAC
11.3.8.1. Market Revenue and Forecast, By Type (2016-2028)
11.3.8.2. Market Revenue and Forecast, by Application (2016-2028)
11.3.8.3. Market Revenue and Forecast, by End User (2016-2028)
11.3.8.4. Market Revenue and Forecast, By Route of Administration (2016-2028)
11.4. MEA
11.4.1. Market Revenue and Forecast, By Type (2016-2028)
11.4.2. Market Revenue and Forecast, by Application (2016-2028)
11.4.3. Market Revenue and Forecast, by End User (2016-2028)
11.4.4. Market Revenue and Forecast, By Route of Administration (2016-2028)
11.4.5. GCC
11.4.5.1. Market Revenue and Forecast, By Type (2016-2028)
11.4.5.2. Market Revenue and Forecast, by Application (2016-2028)
11.4.5.3. Market Revenue and Forecast, by End User (2016-2028)
11.4.5.4. Market Revenue and Forecast, By Route of Administration (2016-2028)
11.4.6. North Africa
11.4.6.1. Market Revenue and Forecast, By Type (2016-2028)
11.4.6.2. Market Revenue and Forecast, by Application (2016-2028)
11.4.6.3. Market Revenue and Forecast, by End User (2016-2028)
11.4.6.4. Market Revenue and Forecast, By Route of Administration (2016-2028)
11.4.7. South Africa
11.4.7.1. Market Revenue and Forecast, By Type (2016-2028)
11.4.7.2. Market Revenue and Forecast, by Application (2016-2028)
11.4.7.3. Market Revenue and Forecast, by End User (2016-2028)
11.4.7.4. Market Revenue and Forecast, By Route of Administration (2016-2028)
11.4.8. Rest of MEA
11.4.8.1. Market Revenue and Forecast, By Type (2016-2028)
11.4.8.2. Market Revenue and Forecast, by Application (2016-2028)
11.4.8.3. Market Revenue and Forecast, by End User (2016-2028)
11.4.8.4. Market Revenue and Forecast, By Route of Administration (2016-2028)
11.5. Latin America
11.5.1. Market Revenue and Forecast, By Type (2016-2028)
11.5.2. Market Revenue and Forecast, by Application (2016-2028)
11.5.3. Market Revenue and Forecast, by End User (2016-2028)
11.5.4. Market Revenue and Forecast, By Route of Administration (2016-2028)
11.5.5. Brazil
11.5.5.1. Market Revenue and Forecast, By Type (2016-2028)
11.5.5.2. Market Revenue and Forecast, by Application (2016-2028)
11.5.5.3. Market Revenue and Forecast, by End User (2016-2028)
11.5.5.4. Market Revenue and Forecast, By Route of Administration (2016-2028)
11.5.6. Rest of LATAM
11.5.6.1. Market Revenue and Forecast, By Type (2016-2028)
11.5.6.2. Market Revenue and Forecast, by Application (2016-2028)
11.5.6.3. Market Revenue and Forecast, by End User (2016-2028)
11.5.6.4. Market Revenue and Forecast, By Route of Administration (2016-2028)
Chapter 12. Company Profiles
12.1. GlaxoSmithKline plc
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Pfizer, Inc.
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Baxter
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Leo Pharma A/S
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Sanofi
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Dr. Reddy’s Laboratories Ltd.
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Aspen Holdings
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. B. Braun Medical Inc.
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Fresenius SE & Co. KGaA
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Teva Pharmaceutical Industries Ltd.
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
Glossary of Terms